NYT Stock Recent News
NYT LATEST HEADLINES
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
NYT, DDS, NEM and FTDR make the cut as top liquid stocks, with each boasting strong liquidity, growth attributes and operational efficiency.
New York, New York--(Newsfile Corp. - August 14, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced that it will report second quarter 2025 financial results ended June 30, 2025 and provide a business update on the morning of Tuesday, August 19, 2025. About OS Therapies OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.
New York Times Co. (NYT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Investigators have uncovered evidence that Russia is at least in part responsible for a recent hack of the computer system that manages U.S. federal court documents, the New York Times reported on Tuesday, citing several people briefed on the breach.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
New York Times (NYT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
"The Gray Lady" of the media was anything but boring as a stock this week. The New York Times Company (NYT -6.21%), anchored by the iconic daily newspaper, generated its own bullish headlines from its latest quarterly earnings report.
The New York Times Co. (NYT 15.53%), the publisher behind the namesake newspaper and a suite of digital products, reported earnings on August 6, 2025. The company posted adjusted diluted earnings per share (EPS) of $0.58, outpacing the analyst consensus of $0.51 (non-GAAP), and revenue (GAAP) of $685.9 million, which beat GAAP expectations of $670.7 million.
NYT beats Q2 estimates as digital subscriptions and ad revenues climb, driving strong 9.7% year-over-year revenue growth.